Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- PROK
- Price
- 2.02
- Stock movement up
- +0.04 (2.02%)
- Company name
- ProKidney Corp.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 285.92M
- Ent value
- 223.87M
- Price/Sales
- 384.30
- Price/Book
- 0.90
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 26.25%
- 3 year return (CAGR)
- -44.74%
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PROK does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 384.30 |
| Price to Book | 0.90 |
| EV to Sales | 300.90 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 141.55M |
| EPS (TTM) | -0.53 |
| FCF per share (TTM) | -1.09 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 744.00K |
| Gross profit (TTM) | -654.00K |
| Operating income (TTM) | -171.21M |
| Net income (TTM) | -71.03M |
| EPS (TTM) | -0.53 |
| EPS (1y forward) | -0.64 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -87.90% |
| Operating margin (TTM) | -23011.69% |
| Profit margin (TTM) | -9547.45% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 95.32M |
| Net receivables | 1.24M |
| Total current assets | 299.99M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 66.84M |
| Total assets | 351.61M |
| Accounts payable | 1.94M |
| Short/Current long term debt | 4.24M |
| Total current liabilities | 29.06M |
| Total liabilities | 33.27M |
| Shareholder's equity | 318.34M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -111.78M |
| Capital expenditures (TTM) | 34.95M |
| Free cash flow (TTM) | -146.73M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -22.31% |
| Return on Assets | -20.20% |
| Return on Invested Capital | -22.24% |
| Cash Return on Invested Capital | -45.95% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.99 |
| Daily high | 2.07 |
| Daily low | 1.96 |
| Daily Volume | 326K |
| All-time high | 13.78 |
| 1y analyst estimate | 6.25 |
| Beta | 1.82 |
| EPS (TTM) | -0.53 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PROK | S&P500 | |
| Current price drop from All-time high | -85.34% | -1.82% |
| Highest price drop | -96.29% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -63.23% | -10.84% |
| Avg time to new high | 101 days | 12 days |
| Max time to new high | 736 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
285.92M
Marketcap category
Small-cap
Description
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Employees
204
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page